Table 3

Details of patients completing the study and results of some examinations

GFD-oats (n = 42)GFD-oats ⩾8 g (n = 34)GFD-std (n = 50)p Value*
GFD-oats, gluten free diet including oats; GFD-oats ⩾8 g, gluten free diet including at least 8 g of oats daily at the end of the study; GFD-std, standard gluten free diet; IEL, intraepithelial lymphocytes; EMA, antiendomysium antibodies; TGA, antitissue transglutaminase antibodies.
*Significant difference between GFD-oats and GFD-std; GFD-oats ⩾8 g and GFD-std.
Age at inclusion (y) (median (range))7.2 (0.7–15.7)7.2 (0.7–15.7)5.6 (0.8–17.2)0.37; 0.38
Patients <2 y (n (%))11 (26%)9 (26%)12 (24%)>0.99;>0.99
Sex distribution (M:F)1:1.31:1.01:1.3>0.99; 0.75
Length of diet (y) (median (range))1.1 (0.9–1.3)1.1 (0.9–1.2)1.1 (0.9–1.5)0.47; 0.80
Enteropathy at end of study period (n)0020.50; 0.51
IEL count (per 100 enterocytes) (mean (SD) [range])16 (4.5) [6–26]16 (4.0) [9–24]16 (5.0) [3–29]0.84; 0.94
EMA positive at control biopsy (%)3335240.45; 0.38
TGA positive at control biopsy (%)1721100.49; 0.27